Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm, Encourages Inovio Pharmaceuticals, Inc. (INO) Shareholders to Inquire About Securities Fraud Class Action

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Inovio Pharmaceuticals, Inc. ("Inovio†or the "Company†) (NASDAQ: INO) securities between October 10, 2023 and December 26, 2025, inclusive (the "Class Period†). Inovio investors have until April 7, 2026 to file a lead plaintiff motion. IF YOU SUFFERED. ...